Disease/Infection News

RSS

Novel P22-mAb based bELISA assay can help detect antibodies against African swine fever virus

African swine fever (ASF) is a highly infectious and fatal disease of pigs. Due to the complexity of the ASF virus (ASFV) and various clinical forms of the disease, a wide range of highly effective and robust sero-diagnostic assays are required.

2 Sep 2022

Case study shows potential to develop myocarditis following monkeypox infection

A 31-year-old male with confirmed monkeypox infection developed acute myocarditis approximately one week following the onset of monkeypox symptoms, according to a case study published today in JACC: Case Reports.

2 Sep 2022

Analysis sheds light on the delay to recognize airborne transmission of the coronavirus

Millions of people have died of coronavirus infection since 2020 because influential institutions took too long to recognize that it is primarily airborne, and a new University of Colorado Boulder-led historical analysis sheds light on the delay.

2 Sep 2022

Omicron BA.2.75 not more resistant to antibodies than the currently dominating BA.5 variant, study suggests

In a recent study, researchers from Karolinska Institutet in Sweden, and others, have characterised the new omicron variant BA.2.75, comparing its ability to evade antibodies against current and previous variants.

2 Sep 2022

Study uncovers the evolutionary dynamics of SARS-CoV-2 at primary stage of massive vaccination

This study uncovers the evolutionary dynamics of SARS-CoV-2 and epidemiological characteristics of COVID-19 at the primary stage of massive vaccination

2 Sep 2022

CDC provides latest updates on the number of individuals infected with E. coli O157 outbreak strain

A CDC investigation notice update regarding a multistate outbreak of E. coli O157 infections is now live: https://www.cdc.gov/ecoli/2022/o157h7-08-22/index.html

2 Sep 2022

How does ACE2 expression in target cells affect neutralization by antibodies to different spike epitopes?

Researchers evaluated how ACE2 expression in target cells impacts neutralization.

2 Sep 2022

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

Researchers summarized existing data on the immunogenicity of COVID-19 vaccines and the humoral and cellular immune responses against SARS-CoV-2.

2 Sep 2022

What is the risk of BA.5 infection among persons with documented infection with past variants?

A recent correspondence discussed a study in which researchers assessed the infection risk for the SARS-CoV-2 Omicron BA.5 subvariant in vaccinated people exposed to previous SARS-CoV-2 variants.

2 Sep 2022

First update of living systematic review provides a comprehensive summary of studies on the risk of experiencing long COVID

Researchers presented findings from the second version of a living systematic review on long COVID.

2 Sep 2022

The origins, breadth, and resolution of autoreactivity in severe COVID-19

Researchers assessed naïve B cells and autoreactivity in severe COVID-19.

2 Sep 2022

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

Researchers assessed the impact of COVID-19 infection on B-cell and antibody responses to COVID-19 booster vaccination.

2 Sep 2022

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

In a recent JAMA Pediatrics study, scientists analyzed a cohort containing children and adolescents after recovering from COVID-19 to determine the dynamics of neutralizing antibodies.

2 Sep 2022

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

A recent PLoS ONE study detected neutralizing nanobodies against SARS-CoV-2 from nanobody phage display libraries and via in vitro and ex vivo high-throughput screenings.

2 Sep 2022

Globalization and cessation of smallpox vaccination are influencing monkeypox spread

A recent review by Barbara S. Schnierle of the Paul-Ehrlich-Institut, Germany, and published in the journal Viruses summarized the existing knowledge about MPXV, the disease it causes, and the strategies to curb its spread.

1 Sep 2022

Symptoms of monkeypox may not always be evident

A recently published article in the journal JAMA Medical News & Perspectives has stated that some monkeypox infections may be asymptomatic or very mildly symptomatic and, thus, can easily remain unnoticed.

1 Sep 2022

Ebola outbreak could be predicted based on individual risk factor data, research shows

Several years ago, a team of scientists at Lehigh University developed a predictive model to accurately forecast Ebola outbreaks based on climate-driven bat migration.

1 Sep 2022

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of Public Health researchers.

1 Sep 2022

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

In a new study, researchers illustrated that metformin was associated with decreased coronavirus disease 2019 (COVID-19) severity among prediabetic patients.

1 Sep 2022

What is the influence of individual infectiousness variation on COVID-19 spread across households?

In a new study, scientists characterized the effect of individual infectiousness variance on the transmission heterogeneity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among households.

1 Sep 2022

Disease/Infection News

Novel P22-mAb based bELISA assay can help detect antibodies against African swine fever virus

Case study shows potential to develop myocarditis following monkeypox infection

Analysis sheds light on the delay to recognize airborne transmission of the coronavirus

Omicron BA.2.75 not more resistant to antibodies than the currently dominating BA.5 variant, study suggests

Study uncovers the evolutionary dynamics of SARS-CoV-2 at primary stage of massive vaccination

CDC provides latest updates on the number of individuals infected with E. coli O157 outbreak strain

How does ACE2 expression in target cells affect neutralization by antibodies to different spike epitopes?

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

What is the risk of BA.5 infection among persons with documented infection with past variants?

First update of living systematic review provides a comprehensive summary of studies on the risk of experiencing long COVID

The origins, breadth, and resolution of autoreactivity in severe COVID-19

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

Globalization and cessation of smallpox vaccination are influencing monkeypox spread

Symptoms of monkeypox may not always be evident

Ebola outbreak could be predicted based on individual risk factor data, research shows

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

What is the influence of individual infectiousness variation on COVID-19 spread across households?

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News